Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.4000
+0.0500 (2.13%)
NASDAQ· Last Trade: Aug 21st, 1:27 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors